Skip to main content
Erschienen in: Neurological Sciences 8/2022

09.02.2022 | COVID-19 | Original Article Zur Zeit gratis

Acute ischemic stroke and COVID-19 pandemic in Brazil: a comparative study of frequency and risk factors before and during SARS-CoV-2 era

verfasst von: Maria Luiza Benevides, Stefany Elias, Pedro Búrigo Costa, André Luiz Pereira Martins, Gladys Lentz Martins, Fernando Cini Freitas, Jean Costa Nunes

Erschienen in: Neurological Sciences | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

COVID-19 pandemic directly impacted the request for hospital care and medical assistance for several diseases worldwide, as occurred with acute ischemic stroke. The present study sought to compare the incidence and severity of acute ischemic stroke (AIS), in addition to sociodemographic, clinical, and radiological characteristics of patients hospitalized in the prepandemic (2018–2019) and pandemic (2020–2021) eras.

Methods

An incidence case–control, observational, and analytical research was carried out in the Stroke Unit of Hospital Governador Celso Ramos, Florianopolis, Santa Catarina, Brazil, including 171 patients admitted with acute ischemic stroke from April 2018 to April 2019 (prepandemic era) and 148 patients between January 2020 and January 2021 (during pandemic).

Results

The mean incidence of AIS hospital admissions was significantly lower in the pandemic period (CI 95%, 0.2 to 5.6; p = 0.04), being lower in the lockdown periods and when the incidence of new COVID-19 cases increased. Besides, referring to AIS severity, the mean areas of AIS were larger during the pandemic period (p < 0.01), especially in August, September, December, and January (p < 0.05). Sociodemographic and clinical variables did not show any difference between the two periods of the study.

Conclusions

Hospital admissions for AIS decreased in the COVID-19 pandemic, mostly during months of higher incidences of new COVID-19 cases. When the incidence of admissions diminished, an increase in the severity of AIS was observed, characterized by larger areas. These findings might contribute to other similar referral centers in managing public policies related to stroke.
Literatur
1.
Zurück zum Zitat Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M et al (2020) COVID-19: a global challenge with old history, epidemiology and progress so far. Molecules 26:39CrossRef Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M et al (2020) COVID-19: a global challenge with old history, epidemiology and progress so far. Molecules 26:39CrossRef
2.
Zurück zum Zitat Erol MK, Kayıkçıoğlu M, Kılıçkap M, Güler A, Yıldırım A, Kahraman F et al (2020) Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: a nationwide study. Anatol J Cardiol 24:334–342PubMedPubMedCentral Erol MK, Kayıkçıoğlu M, Kılıçkap M, Güler A, Yıldırım A, Kahraman F et al (2020) Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: a nationwide study. Anatol J Cardiol 24:334–342PubMedPubMedCentral
3.
Zurück zum Zitat Pop R, Quenardelle V, Hasiu A, Mihoc D, Sellal F, Dugay MH et al (2020) Impact of the COVID-19 outbreak on acute stroke pathways - insights from the Alsace region in France. Eur J Neurol 27:1783–1787CrossRef Pop R, Quenardelle V, Hasiu A, Mihoc D, Sellal F, Dugay MH et al (2020) Impact of the COVID-19 outbreak on acute stroke pathways - insights from the Alsace region in France. Eur J Neurol 27:1783–1787CrossRef
4.
Zurück zum Zitat Sacco S, Ricci S, Ornello R, Eusebi P, Petraglia L, Toni D, Organization IS (2020) Reduced admissions for cerebrovascular events during COVID-19 outbreak in Italy. Stroke 51:3746–3750CrossRef Sacco S, Ricci S, Ornello R, Eusebi P, Petraglia L, Toni D, Organization IS (2020) Reduced admissions for cerebrovascular events during COVID-19 outbreak in Italy. Stroke 51:3746–3750CrossRef
5.
Zurück zum Zitat Rinkel LA, Prick JCM, Slot RER, Sombroek NMA, Burggraaff J, Groot AE et al (2021) Impact of the COVID-19 outbreak on acute stroke care. J Neurol 268:403–408CrossRef Rinkel LA, Prick JCM, Slot RER, Sombroek NMA, Burggraaff J, Groot AE et al (2021) Impact of the COVID-19 outbreak on acute stroke care. J Neurol 268:403–408CrossRef
6.
Zurück zum Zitat Tejada Meza H, Lambea Gil Á, Sancho Saldaña A, Martínez-Zabaleta M, Garmendia Lopetegui E, López-Cancio Martínez E et al (2020) Impact of COVID-19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain. Eur J Neurol 7:2491–2498CrossRef Tejada Meza H, Lambea Gil Á, Sancho Saldaña A, Martínez-Zabaleta M, Garmendia Lopetegui E, López-Cancio Martínez E et al (2020) Impact of COVID-19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain. Eur J Neurol 7:2491–2498CrossRef
7.
Zurück zum Zitat Siegler JE, Zha AM, Czap AL, Ortega-Gutierrez S, Farooqui M, Liebeskind DS et al (2021) Influence of the COVID-19 pandemic on treatment times for acute ischemic stroke: the Society of Vascular and Interventional Neurology Multicenter Collaboration. Stroke 52:40–47CrossRef Siegler JE, Zha AM, Czap AL, Ortega-Gutierrez S, Farooqui M, Liebeskind DS et al (2021) Influence of the COVID-19 pandemic on treatment times for acute ischemic stroke: the Society of Vascular and Interventional Neurology Multicenter Collaboration. Stroke 52:40–47CrossRef
8.
Zurück zum Zitat Katsanos AH, de Sa BD, Al-Qarni MA, Shawawrah M, McNicoll-Whiteman R, Gould L et al (2021) In-hospital delays for acute stroke treatment delivery during the COVID-19 pandemic. Can J Neurol Sci 48:59–65CrossRef Katsanos AH, de Sa BD, Al-Qarni MA, Shawawrah M, McNicoll-Whiteman R, Gould L et al (2021) In-hospital delays for acute stroke treatment delivery during the COVID-19 pandemic. Can J Neurol Sci 48:59–65CrossRef
9.
Zurück zum Zitat Koge J, Shiozawa M, Toyoda K (2021) Acute stroke care in the with-COVID-19 era: experience at a comprehensive stroke center in Japan. Front Neurol 11:611504CrossRef Koge J, Shiozawa M, Toyoda K (2021) Acute stroke care in the with-COVID-19 era: experience at a comprehensive stroke center in Japan. Front Neurol 11:611504CrossRef
10.
Zurück zum Zitat Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA et al (2013) Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health 1:e259–e281CrossRef Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA et al (2013) Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health 1:e259–e281CrossRef
11.
Zurück zum Zitat Cabral NL, Gonçalves AR, Longo AL, Moro CH, Costa G, Amaral CH et al (2009) Trends in stroke incidence, mortality and case fatality rates in Joinville, Brazil: 1995–2006. J Neurol Neurosurg Psychiatry 80:749–754CrossRef Cabral NL, Gonçalves AR, Longo AL, Moro CH, Costa G, Amaral CH et al (2009) Trends in stroke incidence, mortality and case fatality rates in Joinville, Brazil: 1995–2006. J Neurol Neurosurg Psychiatry 80:749–754CrossRef
12.
Zurück zum Zitat Diegoli H, Magalhães PSC, Martins SCO, Moro CHC, França PHC, Safanelli J et al (2020) Decrease in hospital admissions for transient ischemic attack, mild, and moderate stroke during the COVID-19 era. Stroke 51:2315–2321CrossRef Diegoli H, Magalhães PSC, Martins SCO, Moro CHC, França PHC, Safanelli J et al (2020) Decrease in hospital admissions for transient ischemic attack, mild, and moderate stroke during the COVID-19 era. Stroke 51:2315–2321CrossRef
13.
Zurück zum Zitat Pearce N (2005) A short introduction to epidemiology. Centre for Public Health Research, Massey University, Wellington, p 130 Pearce N (2005) A short introduction to epidemiology. Centre for Public Health Research, Massey University, Wellington, p 130
14.
Zurück zum Zitat Kapsner LA, Kampf MO, Seuchter SA, Gruendner J, Gulden C, Mate S et al (2021) Reduced rate of inpatient hospital admissions in 18 German university hospitals during the COVID-19 lockdown. Front Public Health 8:594117CrossRef Kapsner LA, Kampf MO, Seuchter SA, Gruendner J, Gulden C, Mate S et al (2021) Reduced rate of inpatient hospital admissions in 18 German university hospitals during the COVID-19 lockdown. Front Public Health 8:594117CrossRef
15.
Zurück zum Zitat Mafham MM, Spata E, Goldacre R, Gair D, Curnow P, Bray M et al (2020) COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet 396:381–389CrossRef Mafham MM, Spata E, Goldacre R, Gair D, Curnow P, Bray M et al (2020) COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet 396:381–389CrossRef
16.
Zurück zum Zitat Wong JSH, Cheung KMC (2020) Impact of COVID-19 on orthopaedic and trauma service: an epidemiological study. J Bone Joint Surg Am 102:e80CrossRef Wong JSH, Cheung KMC (2020) Impact of COVID-19 on orthopaedic and trauma service: an epidemiological study. J Bone Joint Surg Am 102:e80CrossRef
17.
Zurück zum Zitat Nannoni S, de Groot R, Bell S, Markus HS (2021) Stroke in COVID-19: a systematic review and meta-analysis. Int J Stroke 16:137–149CrossRef Nannoni S, de Groot R, Bell S, Markus HS (2021) Stroke in COVID-19: a systematic review and meta-analysis. Int J Stroke 16:137–149CrossRef
18.
Zurück zum Zitat Luostarinen T, Virta J, Satopää J, Bäcklund M, Kivisaari R, Korja M et al (2020) Intensive care of traumatic brain injury and aneurysmal subarachnoid hemorrhage in Helsinki during the COVID-19 pandemic. Acta Neurochir (Wien) 162:2715–2724CrossRef Luostarinen T, Virta J, Satopää J, Bäcklund M, Kivisaari R, Korja M et al (2020) Intensive care of traumatic brain injury and aneurysmal subarachnoid hemorrhage in Helsinki during the COVID-19 pandemic. Acta Neurochir (Wien) 162:2715–2724CrossRef
19.
Zurück zum Zitat De Filippo O, D’Ascenzo F, Angelini F, Bocchino PP, Conrotto F, Saglietto A et al (2020) Reduced rate of hospital admissions for ACS during COVID-19 outbreak in Northern Italy. N Engl J Med 383:88–89CrossRef De Filippo O, D’Ascenzo F, Angelini F, Bocchino PP, Conrotto F, Saglietto A et al (2020) Reduced rate of hospital admissions for ACS during COVID-19 outbreak in Northern Italy. N Engl J Med 383:88–89CrossRef
20.
Zurück zum Zitat Li Y, Zhou Z, Chen N, He L, Zhou M (2019) Seasonal variation in the occurrence of ischemic stroke: a meta-analysis. Environ Geochem Health 41:2113–2130CrossRef Li Y, Zhou Z, Chen N, He L, Zhou M (2019) Seasonal variation in the occurrence of ischemic stroke: a meta-analysis. Environ Geochem Health 41:2113–2130CrossRef
Metadaten
Titel
Acute ischemic stroke and COVID-19 pandemic in Brazil: a comparative study of frequency and risk factors before and during SARS-CoV-2 era
verfasst von
Maria Luiza Benevides
Stefany Elias
Pedro Búrigo Costa
André Luiz Pereira Martins
Gladys Lentz Martins
Fernando Cini Freitas
Jean Costa Nunes
Publikationsdatum
09.02.2022
Verlag
Springer International Publishing
Schlagwort
COVID-19
Erschienen in
Neurological Sciences / Ausgabe 8/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-022-05873-8

Weitere Artikel der Ausgabe 8/2022

Neurological Sciences 8/2022 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.